UpToDate vs Epocrates

UpToDate vs Epocrates: what each costs and what each is good at

UpToDate and Epocrates get compared constantly, usually by a clinician deciding which subscription to keep. It is a fair question, and the answer is less about which is better than about which job you are hiring the tool to do.

UpToDate is the reference you open when you want to understand a condition properly, with topics written and graded by physician editors. Epocrates is the app you open in the corridor to check a dose, identify a pill or run a quick interaction check. One is for reading, one is for looking up. This page compares them on cost, depth and speed, and is honest about where both leave a gap at the moment you actually sign a prescription.

The Monograph Desk

Ready to check

Drug / scenario + Second drug / context

Press Run check to see the interaction, contraindication, and dosing decision-support card for this scenario.

Illustrative sample · decision-support only · verify against official sources

Interaction

Contraindication / allergy check

Dosing guidance (renal / hepatic)

Guideline-based alternatives

Sources

Illustrative sample · not real clinical advice · you verify and decide

Clinician-in-the-loop

Checked in · you review & sign

Decision support for licensed clinicians. Prescriber.io does not diagnose or prescribe and is not a substitute for professional clinical judgment.

See the comparison

Check · flag · suggest · you review and sign off

The short answer

UpToDate vs Epocrates, in brief

UpToDate is a deep clinical reference for reading up on a condition, with individual subscriptions listing around $579 a year. Epocrates is a fast drug lookup with an interaction checker and pill identifier, and Epocrates+ lists at $179.99 a year or $24.99 a month. They are not really rivals: clinicians reach for UpToDate to understand a condition and Epocrates to check a drug in seconds. If what you need is the interaction, contraindication and dose check delivered together at the moment you prescribe, that is a third category, and it is what Prescriber.io does.

Last updated July 2026

Side by side

UpToDate vs Epocrates vs Prescriber.io

All three are capable tools built for different moments. Here is where they differ, including where we are not the answer.

What matters	UpToDate	Epocrates	Prescriber.io
What it is	In-depth clinical reference with graded topic reviews	Fast drug reference with interaction checker and pill identifier	Point-of-care decision-support card for the prescription in front of you
Cost (individual, July 2026)	Individual UpToDate Pro lists around $579 per year	Epocrates+ lists at $179.99 per year, or $24.99 per month	From $39 per clinician per month, billed annually
What you open it for	Understanding a condition and citing a graded recommendation	Checking a drug, a dose or a pill in seconds	Checking whether this prescription is safe to sign as written
Drug interaction checking	Through the integrated drug database (Lexidrug, formerly Lexicomp)	A well-known strength, checked as a separate step	Runs automatically on the scenario you enter, with the other checks
Contraindications and allergy flags	Covered inside the topic content	Available in the drug entry	Surfaced in the same card as the interaction check
Renal and hepatic dose adjustment	Present, looked up per drug	Present, looked up per drug	Surfaced alongside the interaction and contraindication flags
Guideline-based alternatives	Discussed in the topic narrative	Not the focus; it is a lookup tool	Suggested with a one-line rationale for you to consider
Best suited for	Deep reading and defensible recommendations	Quick drug facts on a phone, at speed	The prescribing moment, when several checks must happen at once

Competitor details reflect publicly published information as of July 2026. Products and prices change, so confirm current details with each vendor.

Which one, for whom

Pick the tool that matches the job

Choose UpToDate if

Your questions are about conditions rather than drugs, and you want an edited, graded recommendation you can cite in a note or defend in a case review. It rewards reading. It is also the more expensive of the two by a wide margin, so check whether your institution already licenses it.

Choose Epocrates if

Most of your lookups are drug facts: a dose, an interaction, a pill you cannot identify. It is fast, it lives on your phone, and at $179.99 a year for Epocrates+ it is a modest line item. It is a reference tool, not a decision-support layer, and it does not pretend otherwise.

Add Prescriber.io if

The checks are the bottleneck. Instead of a lookup per question, you enter the scenario once and get interactions, contraindications, renal and hepatic dose adjustments and guideline alternatives together in one card with cited sources. You review each flag, verify against official sources, and sign.

Which is cheaper, UpToDate or Epocrates?

Epocrates, by a clear margin. Epocrates+ lists at $179.99 a year (or $24.99 monthly) as of July 2026, while an individual UpToDate Pro subscription lists at roughly $579 a year. That is close to a threefold difference, and for a clinician paying out of pocket it is the first thing that gets noticed.

The price gap makes sense once you see what you are buying. Epocrates sells you a fast, well-maintained drug reference. UpToDate sells you an editorial operation: thousands of physician authors writing, updating and grading topic reviews. Whether that is worth the difference depends entirely on whether your day is full of drug lookups or clinical questions. Before paying for either, check your hospital or medical library, because institutional licences are common and a lot of clinicians pay twice without realizing it.

Can Epocrates replace UpToDate?

Not for the job UpToDate does. Epocrates answers what this drug is, what it interacts with and how it is dosed. UpToDate answers how to manage this condition, with the reasoning and the grade attached. If you tried to run a complex management decision off a drug reference, you would be missing the argument, not just the detail.

The reverse is also true, and clinicians feel it more often: UpToDate is a slow way to check one dose. That is why plenty of prescribers keep a cheap drug reference on the phone and a deeper reference on the desk, and why the two subscriptions coexist rather than compete.

Where both leave a gap: the moment you sign

Both tools wait to be asked. To catch a problem with the script in front of you, you have to think to check the interaction, then think to check the contraindication, then think to check the renal dose, then think about whether a different agent would be safer. Four questions, four lookups, on an afternoon that is already running behind. The checks that get skipped are the ones nobody thought to run.

Prescriber.io turns that into one step. Enter the drug or the scenario and it checks interactions, flags contraindications and allergy blockers, surfaces renal and hepatic dose adjustments and suggests guideline-based alternatives, in a single card with cited sources. It is decision-support for licensed clinicians, not autonomous prescribing: you review every flag, verify against official sources, and sign.

See the check run on a scenario of your own

Interactions, contraindications, renal and hepatic dosing and guideline alternatives, in one card you review and sign off on.

Good questions

UpToDate vs Epocrates, answered

For drug facts at speed, Epocrates. For understanding and defending a management decision, UpToDate. Prescribers whose bottleneck is the safety check at the point of signing (interactions, contraindications, renal dosing) are better served by a decision-support tool that runs those checks together rather than one lookup at a time.

Epocrates+ lists at $179.99 a year, or $24.99 a month, as of July 2026. Group licensing is available for practices. Prices change, so confirm the current rate on the vendor site before subscribing.

Yes. Epocrates has a well-established interaction checker and it is one of the main reasons clinicians keep the app. You run it as a separate step, entering the drugs you want checked, rather than it running automatically against the prescription you are writing.

Only if your day genuinely contains both kinds of question. Many clinicians keep the drug reference and drop the deeper reference once their institution provides it, or the other way round. Check what your hospital or medical library already licenses before paying for either.

Keep comparing

Run the prescribing checks in one card

Whichever reference you keep, the interaction, contraindication and dose checks still have to happen. Prescriber.io runs them together and cites its sources. You review, verify, and sign.

See pricing

Decision-support for licensed clinicians. Prescriber.io does not diagnose or prescribe autonomously and is not a substitute for professional clinical judgment. Always verify against official sources.